Andrea Charles | 09/27/2010
Pharma stakeholders are hesitant to fully embrace social media, due to the industry’s highly regulated nature and need to control PR. Fear of social networking In an article on why pharma fears social networking, Jim Edwards, Senior Editor at BrandWeek said: "Marketers fear that user-generated content will include complaints about injuries caused by their drugs’ side effects. The law requires these "adverse events" to be reported to the FDA. The FDA’s adverse-event databases are regularly comb...
To continue reading this story Click Here
Upcoming Events
Temperature Control and Logistics North America Summit
September 10 - 12, 2024
Falls Church, VA
Register Now |
View Agenda |
Learn More